A Reflection on Blood Cancer Awareness Month: Patient Spotlight

Propelling the Understanding of Adaptive Immunity

Preview of 'blood' Journal

Dr. Harlan Robins, professor at the Fred Hutchinson Cancer Research Institute, and colleagues develop the first immunosequencing technology to profile the T-cell immune repertoire at scale and with precision, which had never before been possible.